Covidien PLCCOV:NYQ

90.40
0.45 / 0.50%
4.71m
43.38%
1.01
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Sep 22 2014 21:00 BST.

Summary

On Monday, Covidien PLC (COV:NYQ) closed at 90.40, 2.46% below its 52-week high of 92.68, set on Jun 16, 2014.

52-week range
Today
59.72
Oct 07 2013
92.68
Jun 16 2014
Markit short selling activity
Low
Medium
High
Open90.42
Day high--
Day low--
Bid--
Offer--
Previous close90.40
Average volume2.84m
Shares outstanding451.76m
Free float447.27m
P/E (TTM)27.36
Market cap40.84bn USD
EPS (TTM)3.30 USD
Annual div (TTM)1.32 USD
Annual div yield (TTM)1.45%
Div ex-dateJul 25 2014
Div pay-dateAug 19 2014
Next div ex-dateOct 03 2014
Next div pay-dateNov 06 2014
Data delayed at least 15 minutes, as of Sep 22 2014 21:00 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Covidien PLC-0.08%+2.42%+31.19%+43.38%+143.28%
S&P 500 INDEX+0.51%+0.30%+7.37%+16.63%+86.09%
USA/HEALTH CARE+0.38%+2.56%+9.65%+20.74%--
USA/H CARE EQUIP&SUPPL-0.96%+0.58%+8.67%+16.09%--
Data delayed at least 15 minutes, as of Sep 22 2014 21:00 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.